H.C. Wainwright raised the firm’s price target on Sensus Healthcare (SRTS) to $11 from $10 and keeps a Buy rating on the shares. The company reported a top- and bottom-line beat in Q3 amid strong momentum in the Fair Deal agreement, As previously reported,
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRTS: